Baseline Corticosteroid Use and Corticosteroid-Free Clinical Remission in Crohn's Disease Patients Treated With Certolizumab Pegol in the PRECiSE 2 Trial

Sandborn William; Feagan Brian; Lee Scott; Hanauer Stephen

首页> 外文期刊>Inflammatory bowel diseases >Baseline Corticosteroid Use and Corticosteroid-Free Clinical Remission in Crohn's Disease Patients Treated With Certolizumab Pegol in the PRECiSE 2 Trial

【24h】

Baseline Corticosteroid Use and Corticosteroid-Free Clinical Remission in Crohn's Disease Patients Treated With Certolizumab Pegol in the PRECiSE 2 Trial

机译：在PRECiSE 2试验中，接受Certolizumab Pegol治疗的克罗恩病患者的基线皮质类固醇使用量和无皮质类固醇临床缓解

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Inflammatory bowel diseases》 |2012年第12suppla期|共2页
作者
Sandborn William; Feagan Brian; Lee Scott; Hanauer Stephen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Baseline Corticosteroid Use and Corticosteroid-Free Clinical Remission in Crohn's Disease Patients Treated With Certolizumab Pegol in the PRECiSE 2 Trial [J] . Sandborn William, Feagan Brian, Lee Scott, Inflammatory bowel diseases . 2012,第12Suppla期

机译：在PRECiSE 2试验中，接受Certolizumab Pegol治疗的克罗恩病患者的基线皮质类固醇使用量和无皮质类固醇临床缓解
2. Crohn's Disease Behavior as a Risk Factor for Loss of Maintenance of Remission in Patients Treated With Certolizumab Pegol: Results From the PRECiSE 3 Study [J] . Rubin David, Randall Charles, Coarse Jason, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：克罗恩病行为是接受Certolizumab Pegol治疗的患者失去维持缓解的危险因素：PRECiSE 3研究的结果
3. Predictors of Maintenance of Long-term Remission in Crohn's Disease Patients Treated With Certolizumab Pegol: Multivariate and Univariate Analyses From the PRECiSE 3 Study [J] . Sandborn William, Schreiber Stefan, Siegel Corey, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：赛妥珠单抗治疗后克罗恩病患者长期缓解的预测指标：PRECiSE 3研究的多变量和单变量分析
4. Why corticosteroids should not be used as first-line therapy for Crohn's disease [C] . J. M. RHODE Falk Symposium . 2006

机译：为什么皮质类固醇不应被用作克罗恩病的一线治疗
5. Yoga as an adjunctive therapy for Crohn's disease: A review of the effects of exercise and stress reduction on the quality of life and disease progression in Crohn's disease patients. [D] . Zuckerman, Julie. 2012

机译：瑜伽作为克罗恩氏病的辅助疗法：运动和减轻压力对克罗恩氏病患者生活质量和疾病进展的影响综述。
6. The PRECiSE 2 trial of certolizumab pegol a new PEGylated anti-TNF agent in the treatment of Crohn’s disease [O] . David A Schwartz 2008

机译：新型PEG化抗TNF药物certolizumab pegol的PRECiSE 2试验用于治疗克罗恩病
7. P-147 Clinical Efficacy of Certolizumab Pegol in Patients With Crohn’s Disease Based on Moderate versus Severe Activity in the PRECiSE-2 Trial [O] . Stephen Hanauer, Marla Dubinsky, Jason Coarse, 2014

机译：基于预期-2试验的基于中度与严重活动的克罗恩病患者Cerolizumab Pegol临床疗效

Baseline Corticosteroid Use and Corticosteroid-Free Clinical Remission in Crohn's Disease Patients Treated With Certolizumab Pegol in the PRECiSE 2 Trial

著录项

相似文献

相关主题

期刊订阅